3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Colorectal Neoplasms
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
3
osimertinib
2
Trastuzumab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Doxorubicin
2
Cisplatin
2
Biopsy
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
seribantumab
1
sapanisertib
1
relatlimab
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dehydroftorafur
1
defactinib
1
dabrafenib
1
copanlisib
1
cobimetinib
1
cemiplimab
1
capivasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Radio
×
Gastrointestinal
×
Clear all
NCT05344950
2024-09-19
AURA
UNC Lineberger Comprehensive Cancer Center
Completed
13 enrolled